Holen Sie sich die Stockscreener-App
2.35
8.29%
0.18
Handel nachbörslich:
2.30
-0.05
-2.13%
Schlusskurs vom Vortag:
$2.17
Offen:
$2.18
24-Stunden-Volumen:
1.91M
Relative Volume:
0.26
Marktkapitalisierung:
$52.85M
Einnahmen:
$2.05M
Nettoeinkommen (Verlust:
$-23.15M
KGV:
-0.3543
EPS:
-6.6319
Netto-Cashflow:
$-16.93M
1W Leistung:
+21.76%
1M Leistung:
+40.72%
6M Leistung:
+181.20%
1J Leistung:
-13.60%
1-Tages-Spanne:
$2.18
$2.35
1-Wochen-Bereich:
$1.82
$2.68
52-Wochen-Spanne:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
Firmenname
iBio Inc
Sektor
Branche
Telefon
302-355-0650
Adresse
600 Madison Avenue, Suite 1601, New York, NY
Vergleichen Sie IBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
2.35 | 48.80M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Oppenheimer | Outperform |
| 2025-10-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-05-28 | Eingeleitet | Chardan Capital Markets | Buy |
| 2021-11-29 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-01-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-06-26 | Eingeleitet | Alliance Global Partners | Buy |
Alle ansehen
iBio Inc Aktie (IBIO) Neueste Nachrichten
Will iBio Inc. stock continue upward momentumQuarterly Risk Review & Reliable Intraday Trade Plans - ulpravda.ru
How institutional buying supports iBio Inc. stockMarket Correction Analysis & Small Capital Gains - ulpravda.ru
Gains Recap: Is iBio Inc stock supported by strong fundamentalsGap Up & Low Risk High Reward Ideas - moha.gov.vn
IBIO: Potential Rise Amid Promising Developments - StocksToTrade
Mechanistic Validation of Activin E Targeting De-Risks IBIO-610 and Supports Buy Rating on iBio Shares - TipRanks
Surge in iBio: Is It Time to Buy? - StocksToTrade
iBio Inc. (IBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
LifeSci Capital Sets $5 Target as iBio Rises with Antibody Advancements - timothysykes.com
Pharma News: How iBio Inc stock performs in interest rate cyclesPrice Action & Fast Momentum Stock Entry Tips - moha.gov.vn
Best Penny Stocks To ConsiderDecember 10th - MarketBeat
Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat
Breakouts Watch: What dividend safety score for iBio Inc stockJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
LifeSci Capital Maintains IBio Inc(IBIO.US) With Buy Rating, Maintains Target Price $5 - 富途牛牛
iBio Insiders Placed Bullish Bets Worth US$655.0k - Yahoo Finance
LifeSci Capital Initiates IBio Inc(IBIO.US) With Buy Rating, Announces Target Price $5 - 富途牛牛
Will iBio Inc. (0JV0) stock hit analyst forecasts2025 Trade Ideas & Weekly Chart Analysis and Trade Guides - Улправда
Will iBio Inc. stock attract ESG investorsMarket Growth Review & Weekly Breakout Watchlists - DonanımHaber
iBio (IBIO) EV-to-OCF : -0.03 (As of Dec. 18, 2025) - GuruFocus
How iBio Inc. stock performs after earningsAnalyst Upgrade & High Accuracy Trade Alerts - Улправда
Risk Check: Why iBio Inc stock could outperform in 2025Weekly Market Summary & AI Powered Market Trend Analysis - moha.gov.vn
iBio initiated with an Outperform at Oppenheimer - MSN
Manufacturing Stocks To ResearchDecember 8th - MarketBeat
3 Penny Stocks to Watch Now, 12/11/25 - TipRanks
Most Active U.S. Stocks Today: HeartBeam, Nvidia, Tesla, Netflix and Nextdoor Lead Volatile Trade (Dec. 11, 2025) - TechStock²
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
iBio: Obesity Solutions to Drive Stock Momentum - StocksToTrade
Biotech Alert: Searches spiking for these stocks today - TipRanks
3 Penny Stocks to Watch Now, 12/9/25 - TipRanks
iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025) - ts2.tech
Why is Biotech Stock iBio Up over 50%? - TipRanks
Analyst Upgrade: Will iBio Inc stock outperform international peersQuarterly Trade Review & Accurate Intraday Trading Signals - moha.gov.vn
iBio Rockets: Is It a Mirage or Real Boost? - StocksToTrade
iBio’s New Approach: Game Changer or Just Artifice? - timothysykes.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
iBio (IBIO) Price Target Increased by 14.56% to 4.81 - Nasdaq
Can iBio Inc. stock sustain free cash flow growthJuly 2025 Highlights & Technical Entry and Exit Alerts - Newser
Is iBio Inc. (0JV0) stock a fit for income portfoliosQuarterly Market Review & Daily Profit Maximizing Trade Tips - Newser
IBIO: Long-acting antibody pipeline targets obesity gaps, with IND filings and first-in-human trials ahead - TradingView — Track All Markets
Will iBio Inc. (0JV0) stock test record highs in 2025Weekly Risk Summary & Proven Capital Preservation Tips - Newser
IBIO: AI-driven antibody programs target obesity gaps with IND filings and first-in-human trials ahead - TradingView — Track All Markets
Can iBio Inc. stock deliver sustainable ROE2025 Volume Leaders & High Conviction Investment Ideas - Newser
How iBio Inc. stock reacts to oil pricesMarket Movement Recap & High Accuracy Swing Entry Alerts - Newser
Why iBio Inc. (0JV0) stock could rally strongly2025 Bull vs Bear & Safe Capital Growth Tips - Newser
Why iBio Inc. (0JV0) stock trades below fair valueLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser
How iBio Inc. (0JV0) stock responds to job market shiftsEarnings Recap Report & Low Risk High Win Rate Stock Picks - Newser
Why analysts raise outlook for iBio Inc. (0JV0) stockJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Pharos iBio Co., Ltd. announced that it expects to receive KRW 19 billion in funding from Korea Investment Partners Co. Ltd. - marketscreener.com
Aug Patterns: Should I hold or sell iBio Inc stock in 2025New Guidance & Proven Capital Preservation Tips - BỘ NỘI VỤ
iBio (IBIO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Finanzdaten der iBio Inc-Aktie (IBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):